Mosunetuzumab Biosimilar - Research Grade
Product Sizes
1 mg
ICH5026-1MG
5 mg
ICH5026-5MG
10 mg
ICH5026-10MG
25 mg
ICH5026-25MG
50 mg
ICH5026-50MG
200 mg
ICH5026-200MG
100 mg
ICH5026-100MG
500 mg
ICH5026-500MG
1 g
ICH5026-1G
About this Product
- SKU:
- ICH5026
- Additional Names:
- BTCT4465A
- Application:
- Cell-based/Functional Assay
- CE/IVD:
- RUO
- Clonality:
- Recombinant Monoclonal
- Concentration:
- 5 mg/ml
- Extra Details:
- ichorbio's Mosunetuzumab biosimilar is a bispecific, humanized monoclonal antibody with potential antineoplastic activity. Anti-CD20/CD3 bispecific monoclonal antibody BTCT4465A contains two antigen-recognition sites: one for human CD3, a T-cell surface antigen, and one for human CD20, a tumor-associated antigen (TAA) that is exclusively expressed on B cells during most stages of B-cell development and is often overexpressed in B-cell malignancies. Upon administration, BTCT4465A binds to both T cells and CD20-expressing tumor B cells; this cross-links T cells to tumor cells, and may result in a potent cytotoxic T-lymphocyte (CTL) response against CD20-expressing tumor B cells.
- Formulation:
- Sterile, preservative-free, solution in PBS. BSA and Azide free.
- Immunogen:
- CD3e + CD20
- Isotype:
- IgG1
- Purity:
- >90%
- Purification:
- Protein A/G Purified
- Reactivities:
- Human
- Shipping Conditions:
- Blue Ice
- Specificity:
- Detects human CD3/CD20. This non-therapeutic antibody uses the same sequence as the therapeutic antibody Mosunetuzumab.
- Storage Conditions:
- -70[o]C Avoid freeze/thaw cycles., 2-8[o]C
- Supplier:
- ichorbio
- Type:
- Antibody: Biosimilar Antibody
- Shipping Costs:
- Free shipping to UK Customers
- Manufacturer's Data Sheet:https://ichor.bio/productpdf/print/index/url_key/mosunetuzumab-biosimilar-research-grade/
